Skip to content

Co-treatment with letrozole in patients with polycystic ovary syndrome undergoing ovulation induction for IVFICSI A multicenter randomized parallel controlled clinical study

Co-treatment with letrozole in patients with polycystic ovary syndrome undergoing ovulation induction for IVFICSI A multicenter randomized parallel controlled clinical study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096899
Enrollment
Unknown
Registered
2025-02-08
Start date
2024-01-03
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS

Interventions

LE group:Routine antagonist protocol combined with letrozole for ovulation induction. Letrozole 2.5mg once per day starts from ovulation stimulation day and continues until HCG injection day.
Control group:Routine antagonist protocol

Sponsors

Sun Yat sen Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 42 Years

Inclusion criteria

Inclusion criteria: (1) Women under the age of 42; (2) There are medical indications for IVF/ICSI treatment, and this is the first/second IVF/ICSI treatment; (3) Women diagnosed with PCOS according to Rotterdam criteria; The diagnostic criteria for PCOS are: 1) infrequent ovulation/anovulation; 2) Clinical Kaohsiung/Biochemical Kaohsiung; 3) Polycystic changes in the ovaries; The above three criteria meet any two criteria and exclude other diseases that cause hyperandrogenicity (congenital adrenal hyperplasia, Cushing's syndrome, tumors that secrete androgens, etc.). (4) Obtain written informed consent.

Exclusion criteria

Exclusion criteria: (1) Repeated implantation failures (previous 3 or more IVF/ICSI-ET failures); (2) Untreated endometrial disease; (3) Existence of hydrosalpinx without surgical correction; (4) Diagnosed as endometriosis (stage III or IV); (5) Using donated oocytes to aid in pregnancy; (6) Accepting pre implantation genetic testing; (7) History of recurrent spontaneous abortion.

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rate per initial ovulation induction cycle ;

Countries

China

Contacts

Public ContactYu Li

Sun Yat-sen memorial hospital

liyuliyu0922@163.com+86 136 6014 1860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026